EICHORCondition: Warm Antibody Autoimmune Hemolytic Anemia · Sponsor: Hutchmed
Phase II Study: To evaluate the safety and preliminary efficacy of HMPL-523 in adult patients with wAIHA. Phase III Study(Part A): Confirmation of Efficacy safety and of HMPL-523 in adult patients with wAIHA. Phase III Study (Part B): To further evaluate the long-term safety and tolerability of HMPL-523 in adult patients with wAIHA.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Fuyang Hospital Of Anhui Medical University | Fuyang, Anhui, China | — |
| Fujian Medical University Union Hospital | Fuzhou, Fujian, China | — |
| Lanzhou University Second Hospital | Lanzhou, Gansu, China | — |
| Nanfang hospital | Guangzhou, Guangdong, China | — |
| Shenzhen Second People's Hospital | Shenzhen, Guangdong, China | — |
| Affiliated Hospital of Guangdong Medical University | Zhanjiang, Guangdong, China | — |
| Guilin Medical College Affiliated Hospital | Guilin, Guangxi, China | — |
| Hainan General Hospital | Haikou, Hainan, China | — |
| Affiliated hospital of Hebei university | Baoding, Hebei, China | — |
| Affiliated hospital of chengde medical university | Chengde, Hebei, China | — |
| Harbin First Hospital | Harbin, Heilongjiang, China | — |
| The First Affiliated Hospital of Henan University Of Science and Technology | Luoyang, Henan, China | — |
+ 27 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05535933